Misonix Inc (MSON) 6.21 $MSON Misonix President
Post# of 273257
Posted On: 09/04/2016 7:02:43 AM
Misonix Inc (MSON) 6.21 $MSON
Misonix President and Chief Executive Officer to Retire
PR Newswire - Mon Aug 29, 7:30AM CDT
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced that, effective September 2, 2016, Michael A. McManus, Jr. is resigning as a Director and Chairman of the Board of Directors of Misonix and retiring as the Company's President and Chief Executive Officer.
MSON: 6.21 (+0.10)
BoneScalpel® Hands-On Workshop Draws 20 Surgeons at the 2016 Scoliosis Research Society Worldwide Conference in Bali, Indonesia
PR Newswire - Thu Aug 25, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, hosted a successful BoneScalpel Hands-On Workshop during the Scoliosis Research Society ("SRS"
Worldwide Conference, 2016 held in Bali, Indonesia last week. Twenty surgeons attended the workshop and received training on the use of BoneScalpel for various spinal surgery procedures with an emphasis on scoliosis.
MSON: 6.21 (+0.10)
BoneScalpel® Receives Positive Reception From Oral-Maxillofacial Surgeons at Major Taiwanese Conference and Cadaveric Workshop
PR Newswire - Tue Aug 23, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, received a positive reception to the BoneScalpel's ultrasonic technology from more than 60 oral-maxillofacial surgeons attending the Taiwan Association of Maxillofacial Surgeons Forum on Contemporary Facial Skeletal Surgery held in Hualien, Taiwan on August 16-17.
MSON: 6.21 (+0.10)
Uptrend Call Working As Misonix Stock Rises 22.7% (MSON)
Comtex SmarTrend(R) - Fri Aug 19, 1:51PM CDT
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on July 8th, 2016 at $5.53. In approximately 1 month, Misonix has returned 22.71% as of today's recent price of $6.78.
MSON: 6.21 (+0.10)
Misonix Supports Uganda Spine Mission For Fifth Consecutive Year
PR Newswire - Thu Aug 11, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced its annual support for the Uganda Spine Surgery Mission organized by leading spine surgeon Isador Lieberman, MD, from the Texas Back Institute in Plano, Texas.
MSON: 6.21 (+0.10)
Misonix, Inc. Announces Exclusive Agreement with SonoSpine, LLC
PR Newswire - Wed Aug 10, 9:54AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced a partnership with SonoSpine, LLC ("SonoSpine", an international neurosurgical practice specializing in ultrasonic spine surgery (www.sonospinesurgery.com). Misonix's innovative ultrasonic devices paired with SonoSpine's revolutionary approach to spine surgery is expected to accelerate the development and application of next generation ultrasonic surgery.
MSON: 6.21 (+0.10)
Misonix Down 44.7% Since SmarTrend Downtrend Call (MSON)
Comtex SmarTrend(R) - Tue Jun 07, 12:53PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 7 months, Misonix has returned 44.74% as of today's recent price of $5.17.
MSON: 6.21 (+0.10)
BoneScalpel® Featured in the Lecture and Workshop at 9th Congress of the Chinese Association of Orthopedic Surgeons Meeting
PR Newswire - Tue May 24, 6:30AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that the BoneScalpel was featured in a presentation before the Congress of the Chinese Association of Orthopedic Surgeons Meeting this week in Chengdu, China. Additionally, Misonix participated in the Master Techniques in Spine Surgery Workshop on May 20, 2016 at the PARTI Center, Huashan Hospital, Fudan University and Chengdu International Exhibition and Convention Center located in Shanghai. This workshop was jointly planned by the Chinese Association of Orthopaedic Surgeons (CAOS) and The North American Spine Society (NASS).
MSON: 6.21 (+0.10)
BoneScalpel to be Featured at Master Techniques in Spine Surgery Workshop at Upcoming Ninth Congress of the Chinese Association of Orthopedic Surgeons Meeting
PR Newswire - Wed May 18, 6:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that it will be participating in the Master Techniques in Spine Surgery Workshop on May 20, 2016 at the PARTI Center, Huashan Hospital, Fudan University and Chengdu International Exhibition and Convention Center (CIECC) located in Shanghai and Chengdu China respectively.
MSON: 6.21 (+0.10)
Misonix Features New BoneScalpel® MIS at SpineWeek 2016 In Singapore
PR Newswire - Mon May 16, 1:26PM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that it will be exhibiting at the 2016 SpineWeek conference in Singapore, to take place from May 16 to May 20, 2016.
MSON: 6.21 (+0.10)
Downtrend Call Working As Misonix Stock Falls 43.8% (MSON)
Comtex SmarTrend(R) - Fri May 06, 1:02PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 6 months, Misonix has returned 43.79% as of today's recent price of $5.26.
MSON: 6.21 (+0.10)
Misonix reports 3Q loss
Automated Insights - Thu May 05, 5:02PM CDT
FARMINGDALE, N.Y. (AP) _ Misonix Inc. (MSON) on Thursday reported a fiscal third-quarter loss of $679,000, after reporting a profit in the same period a year earlier.
MSON: 6.21 (+0.10)
Misonix, Inc. Announces Third Quarter and Nine-Months 2016 Financial Results
PR Newswire - Thu May 05, 3:01PM CDT
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the third quarter and the nine-months of fiscal year 2016 ended March 31, 2016.
MSON: 6.21 (+0.10)
37.7% Return Seen to Date on SmarTrend Misonix Call (MSON)
Comtex SmarTrend(R) - Fri Apr 29, 12:49AM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 6 months, Misonix has returned 37.68% as of today's recent price of $5.83.
MSON: 6.21 (+0.10)
Misonix Has Returned 37.4% Since SmarTrend Recommendation (MSON)
Comtex SmarTrend(R) - Thu Apr 21, 1:18PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 6 months, Misonix has returned 37.36% as of today's recent price of $5.86.
MSON: 6.21 (+0.10)
Misonix Shares Down 33.8% Since SmarTrend's Sell Call (MSON)
Comtex SmarTrend(R) - Wed Apr 06, 1:08PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 5 months, Misonix has returned 33.83% as of today's recent price of $6.19.
MSON: 6.21 (+0.10)
Misonix Launches New Vacuum Assisted Ultrasonic Wound Debridement Technology at Diabetic Limb Salvage Conference in Washington D.C.
PR Newswire - Mon Apr 04, 7:45AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced the launch of its newest addition to the SonicOne® platform, SonicVac(TM). This is the first time that the removal of debris and infected tissues is combined with ultrasonic wound debridement.
MSON: 6.21 (+0.10)
Four Clinical Abstracts Demonstrate the Effectiveness of SonicOne® O.R. in Wound Treatment
PR Newswire - Fri Apr 01, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced four clinical abstract presentations were made at the 2016 Diabetic Limb Salvage Conference in Washington, D.C. The conference is taking place from March 31 through April 2, 2016. The new data demonstrated the value in using ultrasonic technology in debriding wounds.
MSON: 6.21 (+0.10)
Misonix President and Chief Executive Officer to Retire
PR Newswire - Mon Aug 29, 7:30AM CDT
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced that, effective September 2, 2016, Michael A. McManus, Jr. is resigning as a Director and Chairman of the Board of Directors of Misonix and retiring as the Company's President and Chief Executive Officer.
MSON: 6.21 (+0.10)
BoneScalpel® Hands-On Workshop Draws 20 Surgeons at the 2016 Scoliosis Research Society Worldwide Conference in Bali, Indonesia
PR Newswire - Thu Aug 25, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, hosted a successful BoneScalpel Hands-On Workshop during the Scoliosis Research Society ("SRS"
Worldwide Conference, 2016 held in Bali, Indonesia last week. Twenty surgeons attended the workshop and received training on the use of BoneScalpel for various spinal surgery procedures with an emphasis on scoliosis. MSON: 6.21 (+0.10)
BoneScalpel® Receives Positive Reception From Oral-Maxillofacial Surgeons at Major Taiwanese Conference and Cadaveric Workshop
PR Newswire - Tue Aug 23, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, received a positive reception to the BoneScalpel's ultrasonic technology from more than 60 oral-maxillofacial surgeons attending the Taiwan Association of Maxillofacial Surgeons Forum on Contemporary Facial Skeletal Surgery held in Hualien, Taiwan on August 16-17.
MSON: 6.21 (+0.10)
Uptrend Call Working As Misonix Stock Rises 22.7% (MSON)
Comtex SmarTrend(R) - Fri Aug 19, 1:51PM CDT
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on July 8th, 2016 at $5.53. In approximately 1 month, Misonix has returned 22.71% as of today's recent price of $6.78.
MSON: 6.21 (+0.10)
Misonix Supports Uganda Spine Mission For Fifth Consecutive Year
PR Newswire - Thu Aug 11, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced its annual support for the Uganda Spine Surgery Mission organized by leading spine surgeon Isador Lieberman, MD, from the Texas Back Institute in Plano, Texas.
MSON: 6.21 (+0.10)
Misonix, Inc. Announces Exclusive Agreement with SonoSpine, LLC
PR Newswire - Wed Aug 10, 9:54AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced a partnership with SonoSpine, LLC ("SonoSpine"
, an international neurosurgical practice specializing in ultrasonic spine surgery (www.sonospinesurgery.com). Misonix's innovative ultrasonic devices paired with SonoSpine's revolutionary approach to spine surgery is expected to accelerate the development and application of next generation ultrasonic surgery. MSON: 6.21 (+0.10)
Misonix Down 44.7% Since SmarTrend Downtrend Call (MSON)
Comtex SmarTrend(R) - Tue Jun 07, 12:53PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 7 months, Misonix has returned 44.74% as of today's recent price of $5.17.
MSON: 6.21 (+0.10)
BoneScalpel® Featured in the Lecture and Workshop at 9th Congress of the Chinese Association of Orthopedic Surgeons Meeting
PR Newswire - Tue May 24, 6:30AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that the BoneScalpel was featured in a presentation before the Congress of the Chinese Association of Orthopedic Surgeons Meeting this week in Chengdu, China. Additionally, Misonix participated in the Master Techniques in Spine Surgery Workshop on May 20, 2016 at the PARTI Center, Huashan Hospital, Fudan University and Chengdu International Exhibition and Convention Center located in Shanghai. This workshop was jointly planned by the Chinese Association of Orthopaedic Surgeons (CAOS) and The North American Spine Society (NASS).
MSON: 6.21 (+0.10)
BoneScalpel to be Featured at Master Techniques in Spine Surgery Workshop at Upcoming Ninth Congress of the Chinese Association of Orthopedic Surgeons Meeting
PR Newswire - Wed May 18, 6:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that it will be participating in the Master Techniques in Spine Surgery Workshop on May 20, 2016 at the PARTI Center, Huashan Hospital, Fudan University and Chengdu International Exhibition and Convention Center (CIECC) located in Shanghai and Chengdu China respectively.
MSON: 6.21 (+0.10)
Misonix Features New BoneScalpel® MIS at SpineWeek 2016 In Singapore
PR Newswire - Mon May 16, 1:26PM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that it will be exhibiting at the 2016 SpineWeek conference in Singapore, to take place from May 16 to May 20, 2016.
MSON: 6.21 (+0.10)
Downtrend Call Working As Misonix Stock Falls 43.8% (MSON)
Comtex SmarTrend(R) - Fri May 06, 1:02PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 6 months, Misonix has returned 43.79% as of today's recent price of $5.26.
MSON: 6.21 (+0.10)
Misonix reports 3Q loss
Automated Insights - Thu May 05, 5:02PM CDT
FARMINGDALE, N.Y. (AP) _ Misonix Inc. (MSON) on Thursday reported a fiscal third-quarter loss of $679,000, after reporting a profit in the same period a year earlier.
MSON: 6.21 (+0.10)
Misonix, Inc. Announces Third Quarter and Nine-Months 2016 Financial Results
PR Newswire - Thu May 05, 3:01PM CDT
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the third quarter and the nine-months of fiscal year 2016 ended March 31, 2016.
MSON: 6.21 (+0.10)
37.7% Return Seen to Date on SmarTrend Misonix Call (MSON)
Comtex SmarTrend(R) - Fri Apr 29, 12:49AM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 6 months, Misonix has returned 37.68% as of today's recent price of $5.83.
MSON: 6.21 (+0.10)
Misonix Has Returned 37.4% Since SmarTrend Recommendation (MSON)
Comtex SmarTrend(R) - Thu Apr 21, 1:18PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 6 months, Misonix has returned 37.36% as of today's recent price of $5.86.
MSON: 6.21 (+0.10)
Misonix Shares Down 33.8% Since SmarTrend's Sell Call (MSON)
Comtex SmarTrend(R) - Wed Apr 06, 1:08PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 5 months, Misonix has returned 33.83% as of today's recent price of $6.19.
MSON: 6.21 (+0.10)
Misonix Launches New Vacuum Assisted Ultrasonic Wound Debridement Technology at Diabetic Limb Salvage Conference in Washington D.C.
PR Newswire - Mon Apr 04, 7:45AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced the launch of its newest addition to the SonicOne® platform, SonicVac(TM). This is the first time that the removal of debris and infected tissues is combined with ultrasonic wound debridement.
MSON: 6.21 (+0.10)
Four Clinical Abstracts Demonstrate the Effectiveness of SonicOne® O.R. in Wound Treatment
PR Newswire - Fri Apr 01, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced four clinical abstract presentations were made at the 2016 Diabetic Limb Salvage Conference in Washington, D.C. The conference is taking place from March 31 through April 2, 2016. The new data demonstrated the value in using ultrasonic technology in debriding wounds.
MSON: 6.21 (+0.10)
(0)
(0)Scroll down for more posts ▼